López-Royo M P, Ortiz-Lucas M, Gómez-Trullén E M, Herrero P
iPhysio Reaserch Group, Universidad San Jorge, Campus Universitario, Autov. A23, Km 299, Villanueva de Gállego, Zaragoza 50830, Spain.
Universidad de Zaragoza, Facultad de Ciencias de la Salud, Dpto. de Fisiatría y Enfermería, C/Domingo Miral s/n, Zaragoza 50009, Spain.
Evid Based Complement Alternat Med. 2020 Sep 5;2020:8706283. doi: 10.1155/2020/8706283. eCollection 2020.
The aim was to determine the effectiveness of minimally invasive techniques (MIT) in patients with patellar tendinopathy. Database searches were performed for randomized controlled trials (RCTs) in electronic databases (WOS, Cochrane Central, SportDiscus, and Medline via PubMed and PEDro). The inclusion criteria used were published in English or Spanish and involving adults with patellar tendinopathy (pain on the inferior pole of the patella for a minimum of 3 months), with at least one group receiving MIT. The quality of the relevant RCTs was evaluated using the PEDro scale. The primary outcome was functionality using the VISA-p questionnaire. Secondary outcome was focused on pain. A total of 1164 studies were screened for possible inclusion in our systematic review. Finally, 10 RCTs were included with a total of 326 individuals. Five RCTs were included in the meta-analysis. The quality assessment revealed that all the studies included were considered to possess high methodological quality. All studies analyzing MIT such as platelet-rich plasma (PRP), dry needling, or skin-derived tenocyte-like cells, when combined with exercise, proved to be effective for patellar tendinopathy. Moreover, the PRP technique with doses greater than 4 mL together and combined with an exercise program lasting over 6 weeks obtained better results in functionality and pain than other treatments in the short term. However, in the long term, dry needling and skin-derived tenocyte-like cells are more effective than PRP. Although the infiltration of drugs was effective at posttreatment, these improvements were not maintained over time and may have secondary effects. Although there are no RCTs analyzing the effectiveness of MIT like percutaneous needle electrolysis, there has been an increasing number of publications achieving excellent results in the last years. However, it is necessary to develop RCTs analyzing not only the effect but also comparing the effectiveness between different MIT such as dry needling and percutaneous needle electrolysis.
目的是确定微创技术(MIT)对髌腱病患者的有效性。在电子数据库(通过PubMed和PEDro检索的WOS、Cochrane Central、SportDiscus和Medline)中进行数据库搜索,以查找随机对照试验(RCT)。纳入标准为以英文或西班牙文发表,涉及患有髌腱病的成年人(髌骨下极疼痛至少3个月),且至少有一组接受MIT治疗。使用PEDro量表评估相关RCT的质量。主要结局是使用VISA-p问卷评估功能。次要结局集中在疼痛方面。共筛选了1164项研究以确定是否可能纳入我们的系统评价。最终,纳入了10项RCT,共326名个体。5项RCT纳入了荟萃分析。质量评估显示,所有纳入的研究均被认为具有较高的方法学质量。所有分析MIT的研究,如富血小板血浆(PRP)、干针疗法或皮肤源性肌腱细胞样细胞,与运动相结合时,均被证明对髌腱病有效。此外,剂量大于4 mL的PRP技术与持续超过6周的运动计划相结合,在短期内比其他治疗方法在功能和疼痛方面取得了更好的效果。然而,从长期来看,干针疗法和皮肤源性肌腱细胞样细胞比PRP更有效。尽管药物注射在治疗后有效,但这些改善并未随时间维持,且可能有副作用。尽管没有RCT分析如经皮针电解等MIT的有效性,但近年来有越来越多的出版物取得了优异的结果。然而,有必要开展RCT,不仅分析效果,还要比较不同MIT(如干针疗法和经皮针电解)之间的有效性。